Eloi Coco Industries Expands Business Portfolio through Investment in Natural Medicine Sector

PT Eloi Coco Industries is expanding its business portfolio by investing in the Natural Medicine (OBA) sector. This expansion marks a significant transformation for the company, moving from the fragrance and personal care industry towards the high-value health and wellness segment.

“Entering the Natural Medicine sector is a concrete step for PT Eloi Coco Industries to optimise the potential of Indonesia’s natural resource wealth, combined with modern manufacturing standards,” said the Project Manager of PT Eloi Coco Industries.

Apriani stated that as part of this expansion, PT Eloi Coco Industries is currently strengthening its manufacturing facilities and production capabilities to be ready to produce various lines of natural medicine products that are practical and relevant to modern society. The product lines to be produced include inhalers, essential oil roll-ons, and high-quality traditional medicated oils (minyak telon).

“Our main focus at this time is to build a solid production and research foundation, including the readiness to implement CPOBAB (Good Manufacturing Practices for Natural Medicines), so that we can provide products such as inhaler, roll-on, and minyak telon that are safe, high-quality, and trusted by the public,” Apriani added.

PT Eloi Coco Industries is prioritising compliance with national regulatory standards through the implementation of Good Manufacturing Practices for Natural Medicines (CPOBAB). Adherence to CPOBAB ensures that all stages—from formulation, production processes, and quality control to distribution—operate under strict safety and consistency standards.

“This investment confirms the ambition of PT Eloi Coco Industries to grow as a leading Indonesian consumer goods company with an increasingly broad and sustainable product portfolio,” concluded Apriani.